Literature DB >> 31535145

Changes in cardiac Aquaporin expression during aortic valve replacement surgery with cardiopulmonary bypass.

María Teresa Politi1, Federico Ochoa1, Vanina Netti1, Raúl Ferreyra2, Guillermo Bortman2, Norberto Sanjuan3, Celina Morales4, Antonio Piazza5, Claudia Capurro1.   

Abstract

OBJECTIVES: Cardiopulmonary bypass (CPB) use is an essential strategy for many cardiovascular surgeries. However, its use and duration have been associated with a higher rate of postoperative complications, such as low cardiac output syndrome due to myocardial oedema and dysfunction. Though Aquaporin water channels have been implicated in myocardial water balance, their specific role in this clinical scenario has not been established.
METHODS: In a consecutive study of 17 patients with severe aortic stenosis undergoing aortic valve replacement surgery, 2 myocardial biopsies of the left ventricle were taken: 1 before and 1 after CPB use. Sociodemographic, clinical and laboratory data were collected. Western blot and immunohistochemistry studies were performed.
RESULTS: After CPB use, there was a mean increase of ∼62% in Aquaporin 1 protein levels (P = 0.001) and a mean reduction of ∼38% in Aquaporin 4 protein levels (P = 0.030). In immunohistochemistry assays, Aquaporin 1 was found lining small blood vessels, while Aquaporin 4 formed a circular label in cardiomyocytes. There were no changes in the localization of either protein following CPB use. During the observed on-pump time interval, there was a 1.7%/min mean increase in Aquaporin 1 (P = 0.021) and a 2.5%/min mean decrease in Aquaporin 4 (P = 0.018). Myocardial interstitial oedema increased by 42% (95% confidence interval 31-54%) after CPB use. Patients who developed low cardiac output syndrome were in the upper half of the median percentage change of Aquaporin expression.
CONCLUSION: Time-dependent changes in cardiac Aquaporin expression may be associated with myocardial oedema and dysfunction related to CPB use.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic valve; Aquaporins; Cardiopulmonary bypass; Humans; Myocardium; Oedema

Mesh:

Substances:

Year:  2020        PMID: 31535145     DOI: 10.1093/ejcts/ezz249

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass.

Authors:  Hai Wang; Dafa Zhang; Hongbo Qian; Jun Nie; Jun Wei
Journal:  Comput Math Methods Med       Date:  2022-04-01       Impact factor: 2.238

Review 2.  A Cardioplegic Solution with an Understanding of a Cardiochannelopathy.

Authors:  Min Jeong Ji; Jeong Hee Hong
Journal:  Antioxidants (Basel)       Date:  2021-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.